InVivoMAb anti-human pan MHC Class II (HLA II)
BE0452
ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-human pan MHC Class II (HLA II)
- Delivery Days Customer7
- ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDIVA12
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostMouse
- IsotypeIgG1
- ReactivityHuman
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Miranda M, Hansen BE, Wehbi B, et al. FVIII peptides presented on HLA-DP and identification of an A3 domain peptide binding with high affinity to the commonly expressed HLA-DP4. Haematologica. 2025,110(6):1316-1327. doi: 10.3324/haematol.2024.286204Read this paper
- Minowa T, Murata K, Mizue Y, et al. Single-cell profiling of acral melanoma infiltrating lymphocytes reveals a suppressive tumor microenvironment. Sci Transl Med. 2024,16(776):eadk8832. doi: 10.1126/scitranslmed.adk8832Read this paper
- Matsumoto S, Tsujikawa T, Tokita S, et al. HLA class II neoantigen presentation for CD4(+) T cell surveillance in HLA class II-negative colorectal cancer. Oncoimmunology. 2024,13(1):2404665. doi: 10.1080/2162402X.2024.2404665Read this paper
- Tokita S, Fusagawa M, Matsumoto S, et al. Identification of immunogenic HLA class I and II neoantigens using surrogate immunopeptidomes. Sci Adv. 2024,10(38):eado6491. doi: 10.1126/sciadv.ado6491Read this paper
- Palomero J, Panisello C, Lozano-Rabella M, et al. Biomarkers of tumor-reactive CD4(+) and CD8(+) TILs associate with improved prognosis in endometrial cancer. J Immunother Cancer. 2022,10(12). doi: 10.1136/jitc-2022-005443Read this paper
- Casasola-LaMacchia A, Seward RJ, Tourdot S, et al. HLAII peptide presentation of infliximab increases when complexed with TNF. Front Immunol. 2022,13:932252. doi: 10.3389/fimmu.2022.932252Read this paper
- Nicholas B, Bailey A, McCann KJ, et al. Identification of neoantigens in oesophageal adenocarcinoma. Immunology. 2023,168(3):420-431. doi: 10.1111/imm.13578Read this paper
- Sricharoensuk C, Boonchalermvichien T, Muanwien P, et al. Unsupervised Mining of HLA-I Peptidomes Reveals New Binding Motifs and Potential False Positives in the Community Database. Front Immunol. 2022,13:847756. doi: 10.3389/fimmu.2022.847756Read this paper
- Sudhir PR, Lin TD, Zhang Q. HLA Allele-Specific Quantitative Profiling of Type 1 Diabetic B Lymphocyte Immunopeptidome. J Proteome Res. 2022,21(1):250-264. doi: 10.1021/acs.jproteome.1c00842Read this paper
- Peri A, Greenstein E, Alon M, et al. Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma. J Clin Invest. 2021,131(20). doi: 10.1172/JCI129466Read this paper
Datasheet
Related products
Product group Antibodies
References
ApplicationsNeutralisation/Blocking, Other Application
ReactivityMouse
- SizePrice
Product group Antibodies
References
- SizePrice
Product group Antibodies
References
ApplicationsFunctional Assay, Flow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, Neutralisation/Blocking
ReactivityMouse
- SizePrice
Product group Antibodies
References
ApplicationsWestern Blot
ReactivityMouse
- SizePrice
Product group Antibodies
References
ApplicationsFlow Cytometry, Neutralisation/Blocking
ReactivityMouse, Rat
- SizePrice
Product group Antibodies
References
ApplicationsFlow Cytometry, ImmunoPrecipitation, Neutralisation/Blocking
ReactivityMouse
- SizePrice
Product group Antibodies
References
ApplicationsFlow Cytometry, Western Blot, Neutralisation/Blocking, Other Application
ReactivityHuman, Monkey
- SizePrice